Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products Draft Guidance for Industry and Other Interested Parties January 2025

Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products Draft Guidance for Industry and Other Interested Parties January 2025 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-use-artificial-intelligence-support-regulatory-decision-making-drug-and-biological